Trial intelligence / Profile preview

Nesiritide Dose-Finding in Acute Heart Failure

NCT00490724Phase 2Completed

Sponsor
Janssen Pharmaceutical
Start
Mar 2007
Primary completion
Jun 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of nesiritide in Acute Heart Failure (AHF), sponsored by Janssen Pharmaceutical. Started Mar 2007; status: completed.

02

Drugs

nesiritide
03

Conditions

Acute Heart Failure (AHF)

Beyond the preview

Go deeper on NCT00490724.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00490724.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call